131 related articles for article (PubMed ID: 2718607)
1. Improved recombinant LC16m0 or LC16m8 vaccinia virus successfully expressing hepatitis B surface antigen.
Watanabe K; Kobayashi H; Kajiyama K; Morita M; Yasuda A; Gotoh H; Saeki S; Sugimoto M; Saito H; Kojima A
Vaccine; 1989 Feb; 7(1):53-9. PubMed ID: 2718607
[TBL] [Abstract][Full Text] [Related]
2. The immunogenicity of recombinant LC16mO vaccinia virus harboring HBsAg gene in mice.
Watanabe K; Morita M; Sato T; Yausi K; Kojima A
Biologicals; 1991 Apr; 19(2):77-85. PubMed ID: 1888498
[TBL] [Abstract][Full Text] [Related]
3. Recombinant vaccinia virus LC16m0 or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strain.
Morita M; Suzuki K; Yasuda A; Kojima A; Sugimoto M; Watanabe K; Kobayashi H; Kajima K; Hashizume S
Vaccine; 1987 Mar; 5(1):65-70. PubMed ID: 3554809
[TBL] [Abstract][Full Text] [Related]
4. Stability of recombinant vaccinia virus LC16m0 or LC16m8: preserved laboratory attenuation markers and conserved expression of inserted HBsAg gene.
Watanabe K; Morita M; Kojima A
Vaccine; 1989 Dec; 7(6):499-502. PubMed ID: 2609725
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of recombinant vaccinia viruses expressing hepatitis B virus surface antigen in mice.
Grigorieva IM; Grigoriev VG; Zakharova LG; Pashvykina GV; Shevlyagin VY; Altstein AD
Immunol Lett; 1993 Jun; 36(3):267-71. PubMed ID: 8370598
[TBL] [Abstract][Full Text] [Related]
6. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.
Smith GL; Mackett M; Moss B
Nature; 1983 Apr; 302(5908):490-5. PubMed ID: 6835382
[TBL] [Abstract][Full Text] [Related]
7. Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.
Paoletti E; Lipinskas BR; Samsonoff C; Mercer S; Panicali D
Proc Natl Acad Sci U S A; 1984 Jan; 81(1):193-7. PubMed ID: 6320164
[TBL] [Abstract][Full Text] [Related]
8. Antigenic properties of vaccinia virus and of the virus recombinant strains expressing heterologous genes.
Chelyapov NV; Antonova TP; Yanova NN; Chernos VI
Acta Virol; 1988 Sep; 32(5):409-16. PubMed ID: 2904735
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of an attenuated vaccinia virus strain, LC16m0, and its recombinant virus vaccines.
Sugimoto M; Yamanouchi K
Vaccine; 1994 Jun; 12(8):675-81. PubMed ID: 8091843
[TBL] [Abstract][Full Text] [Related]
10. Development of heat-stable recombinant rinderpest vaccine.
Tsukiyama K; Yoshikawa Y; Kamata H; Imaoka K; Asano K; Funahashi S; Maruyama T; Shida H; Sugimoto M; Yamanouchi K
Arch Virol; 1989; 107(3-4):225-35. PubMed ID: 2818208
[TBL] [Abstract][Full Text] [Related]
11. Immunological and virological characterization of improved construction of recombinant vaccinia virus expressing rinderpest virus hemagglutinin.
Asano K; Tsukiyama K; Shibata S; Yamaguchi K; Momoki T; Maruyama T; Kohara M; Miki K; Sugimoto M; Yoshikawa Y
Arch Virol; 1991; 116(1-4):81-90. PubMed ID: 2001178
[TBL] [Abstract][Full Text] [Related]
12. Selection of recombinant vaccinia viruses (Tian Tan strain) expressing hepatitis B virus surface antigen by using beta-galactosidase as a marker.
Liu GQ; Cao X; Zhu JM; Ren GF; Li HM; Xie YX; Peng W
Sci China B; 1990 Feb; 33(2):188-97. PubMed ID: 2111142
[TBL] [Abstract][Full Text] [Related]
13. [Recombinant Oka varicella vaccine as a live hepatitis B virus vaccine].
Shiraki K; Takahara T
Nihon Rinsho; 1993 Jan; 51(1):241-7. PubMed ID: 8381884
[TBL] [Abstract][Full Text] [Related]
14. [A recombinant vaccinia virus expressing the middle preS2-S envelope protein of the hepatitis B virus. The induction of humoral and cellular immunity by the immunization of laboratory animals].
Beliaev AS; Dmitriev IP; Ignat'ev GM; Mizenko GA; Putintseva NI; Sabirov AN; Samukov VV; Semënova LN; Ammosov AD; Rukavishnikov MIu
Dokl Akad Nauk SSSR; 1990; 314(2):488-91. PubMed ID: 2265587
[No Abstract] [Full Text] [Related]
15. Immunogenicity of a recombinant vaccinia virus expressing envelope a glycoprotein of bovine leukaemia virus.
Ohishi K; Maruyama T; Shida H; Nishimaki J; Miki K; Sagata N; Ikawa Y; Sugimoto M
Vaccine; 1988 Oct; 6(5):428-32. PubMed ID: 2848378
[TBL] [Abstract][Full Text] [Related]
16. Live recombinant vaccinia virus protects chimpanzees against hepatitis B.
Moss B; Smith GL; Gerin JL; Purcell RH
Nature; 1984 Sep 6-11; 311(5981):67-9. PubMed ID: 6472464
[TBL] [Abstract][Full Text] [Related]
17. Induction of neutralizing antibodies against bovine leukosis virus in rabbits by vaccination with recombinant vaccinia virus expressing bovine leukosis virus envelope glycoprotein.
Ohishi K; Suzuki H; Maruyama T; Yamamoto T; Funahashi S; Miki K; Ikawa Y; Sugimoto M
Am J Vet Res; 1990 Aug; 51(8):1170-3. PubMed ID: 2167028
[TBL] [Abstract][Full Text] [Related]
18. Construction of recombinant vaccinia virus expressing GM-CSF and its use as tumor vaccine.
Qin HX; Chatterjee SK
Gene Ther; 1996 Jan; 3(1):59-66. PubMed ID: 8929912
[TBL] [Abstract][Full Text] [Related]
19. Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen.
Shiraki K; Hayakawa Y; Mori H; Namazue J; Takamizawa A; Yoshida I; Yamanishi K; Takahashi M
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1393-9. PubMed ID: 1646279
[TBL] [Abstract][Full Text] [Related]
20. Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection.
Hertig C; Pye AD; Hyatt AD; Davis SS; McWilliam SM; Heine HG; Walker PJ; Boyle DB
J Gen Virol; 1996 Apr; 77 ( Pt 4)():631-40. PubMed ID: 8627251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
